An mRNA expression signature for prognostication in de novo acute myeloid leukemia patients with normal karyotype

Although clinical features, cytogenetics, and mutations are widely used to predict prognosis in patients with acute myeloid leukemia (AML), further refinement of risk stratification is necessary for optimal treatment, especially in cytogenetically normal (CN) patients. We sought to generate a simple...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Chuang, Ming-Kai, Chiu, Yu-Chiao, Chou, Wen-Chien, Hou, Hsin-An, Tseng, Mei-Hsuan, Kuo, Yi-Yi, Chen, Yidong, Chuang, Eric Y., Tien, Hwei-Fang
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2015
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4770759/
https://ncbi.nlm.nih.gov/pubmed/26517675
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi